56. ベーチェット病 Behcet disease Clinical trials / Disease details
臨床試験数 : 81 / 薬物数 : 107 - (DrugBank : 30) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04609397 (ClinicalTrials.gov) | November 30, 2020 | 19/10/2020 | A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease | A Phase ? Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease | Behçet Disease | Drug: Hemay005;Other: Placebo | Tianjin Hemay Pharmaceutical Co., Ltd | NULL | Terminated | 18 Years | 75 Years | All | 89 | Phase 2 | China |